Publications
Canadian Journal of Diabetes. Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021) [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85143981743&partnerID=MN8TOARS
. Diabetes Care. Associations of Mid-and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147047452&partnerID=MN8TOARS
. Diabetes Care. Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85165521395&partnerID=MN8TOARS
. Diabetes, Obesity and Metabolism. Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85167588605&partnerID=MN8TOARS
. Drug Safety. Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&partnerID=MN8TOARS
. International Journal of Epidemiology. Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147424628&partnerID=MN8TOARS
. Journal of Pharmaceutical Health Services Research. Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85163707017&partnerID=MN8TOARS
. Diabetes, Obesity and Metabolism. Suicidality among users of glucagon‐like peptide‐1 receptor agonists: An emerging signal? [Internet]. 2024;Available from: https://doi.org/10.1111/dom.15459
. Diabetes, Obesity and Metabolism. Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities [Internet]. 2024;Available from: https://doi.org/10.1111/dom.15385
.